Coming Soon: Omada – a cardio-diabesity prevention programme for eligible customers across all CGHO plans [US residents only]
Omada is an exciting new enhancement to the CGHO product portfolio that is currently in the pipeline, with an aim to launch to eligible customers by Q3 2025.
An innovative, virtual, drug-free weight-loss programme, Omada focuses on the preventing the development of Type 2 Diabetes and other weightassociated health conditions in at-risk populations. It works as a long-term weight management solution, by building healthy habits and promoting future-proof, sustainable weight loss.
As GLP-1 drugs become ever more prominent in the market, it is crucial that customers understand the potential risks, and limitations, of these ‘quick fix’ solutions.
For a customer to be eligible for the programme, they must:
- reside in the US
- be 18 years or older
- have a BMI of over 25 [or 23 in Asian population]
and,
- one or more pre-diabetes diagnoses. *
What does the programme feature?
Omada is completely free for eligible customers [RRP $700].
They will receive a:
- digital smart-scale
- access to an in-app, 1 to 1 health coach
- weekly lessons on nutrition, activity, stress and sleep
- a food, weight and activity tracker
- a virtual community where they can share recipes and support each other on their weight-loss journey
We are confident that the launch of Omada will add significant value to our customer’s experience by assisting them in achieving a healthier version of themselves.
*A diagnosis of one or more of the following: pre-diabetes, high tryglycerides, low HDL, hypertension, elevated blood glucose levels, anxiety, depression, or is a smoker.
Back to homepage